AUSTIN, Texas, July 20, 2023 (GLOBE NEWSWIRE) — Aspira Women’s Health Inc. (“Aspira” or the “Company”) AWH, a bio-analytical based women’s health company focused on the development of gynecologic disease diagnostic tools, today announced that it has entered into definitive agreements with institutional investors, alongside participation from certain longstanding investors…Read More
Aspira Womens Health Announces 47 Million Registered Direct Offering Aspira Womens Health NASDAQAWH
